Jeffrey Dierks - 24 Jan 2024 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol
HRMY
Transactions as of
24 Jan 2024
Net transactions value
$0
Form type
4
Filing time
26 Jan 2024, 16:55:32 UTC
Previous filing
08 Nov 2023
Next filing
11 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Stock Option Award $0 +52,500 $0.000000 52,500 24 Jan 2024 Common Stock 52,500 $30.69 Direct F1
transaction HRMY Restricted Stock Units Award $0 +10,750 $0.000000 10,750 24 Jan 2024 Common Stock 10,750 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
F2 The restricted stock units were granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.